This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thacker, W. L.
Right arrow Articles by Talkington, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thacker, W. L.
Right arrow Articles by Talkington, D. F.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2000, p. 778-780, Vol. 7, No. 5
1071-412X/00/$04.00+0

Analysis of Complement Fixation and Commercial Enzyme Immunoassays for Detection of Antibodies to Mycoplasma pneumoniae in Human Serum

W. Lanier Thacker* and Deborah F. Talkington

Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia 30333

Received 23 December 1999/Returned for modification 5 April 2000/Accepted 14 June 2000

The Meridian ImmunoCard (IC), GenBio ImmunoWELL-IgM, and Remel EIA commercial antibody tests are qualitative enzyme immunoassays that detect antibodies to Mycoplasma pneumoniae in serum. These tests were compared to an M. pneumoniae complement fixation (CF) assay, which uses a commercially available antigen component. The Meridian IC and the ImmunoWELL-IgM detect immunoglobulin M (IgM) only; the Remel EIA and the CF test detect both IgM and IgG antibodies. Detection of specific IgM antibody, which appears early in infection, can be, but is not always, indicative of a recent or current infection. Paired serum samples from 64 adult patients with probable M. pneumoniae infection were examined with each of the four tests. Thirty (47%) of the 64 acute-phase sera were IgM positive by Meridian IC, 26 (41%) were positive by Remel EIA, 24 (38%) were positive by CF, and 15 (23%) were positive by ImmunoWELL-IgM. When both the acute- and convalescent-phase serum samples from each patient were examined, 61 (95%) of the 64 patients were positive by CF, 60 patients (94%) were positive by Remel EIA, 52 patients (81%) were IgM positive by the Meridian IC, and 29 patients (45%) were IgM positive by the ImmunoWELL-IgM assay. The Meridian IC was more sensitive than the other tests for early detection of IgM antibodies. However, after examining paired serum samples, we concluded that the detection of IgM alone may not be useful for all cases of mycoplasma infection, especially in an adult population.

* Corresponding author. Mailing address: Bldg. 5-312, Mailstop G03, CDC, Atlanta, GA 30333. Phone: (404) 639-3563. Fax: (404) 639-4215. E-mail: wlt1{at}cdc.gov.

Clinical and Diagnostic Laboratory Immunology, September 2000, p. 778-780, Vol. 7, No. 5
1071-412X/00/$04.00+0


This article has been cited by other articles:

  • Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., Verheij, T. J. M. (2005). Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138-1180 [Abstract] [Full Text]  
  • Beersma, M. F. C., Dirven, K., van Dam, A. P., Templeton, K. E., Claas, E. C. J., Goossens, H. (2005). Evaluation of 12 Commercial Tests and the Complement Fixation Test for Mycoplasma pneumoniae-Specific Immunoglobulin G (IgG) and IgM Antibodies, with PCR Used as the "Gold Standard". J. Clin. Microbiol. 43: 2277-2285 [Abstract] [Full Text]  
  • Chaudhry, R., Nisar, N., Hora, B., Chirasani, S. R., Malhotra, P. (2005). Expression and Immunological Characterization of the Carboxy-Terminal Region of the P1 Adhesin Protein of Mycoplasma pneumoniae. J. Clin. Microbiol. 43: 321-325 [Abstract] [Full Text]  
  • Waites, K. B., Talkington, D. F. (2004). Mycoplasma pneumoniae and Its Role as a Human Pathogen. Clin. Microbiol. Rev. 17: 697-728 [Abstract] [Full Text]  
  • Talkington, D. F., Shott, S., Fallon, M. T., Schwartz, S. B., Thacker, W. L. (2004). Analysis of Eight Commercial Enzyme Immunoassay Tests for Detection of Antibodies to Mycoplasma pneumoniae in Human Serum. CVI 11: 862-867 [Abstract] [Full Text]  
  • Templeton, K. E., Scheltinga, S. A., Graffelman, A. W., van Schie, J. M., Crielaard, J. W., Sillekens, P., van den Broek, P. J., Goossens, H., Beersma, M. F. C., Claas, E. C. J. (2003). Comparison and Evaluation of Real-Time PCR, Real-Time Nucleic Acid Sequence-Based Amplification, Conventional PCR, and Serology for Diagnosis of Mycoplasma pneumoniae. J. Clin. Microbiol. 41: 4366-4371 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»